Dr. Reddy’s Laboratories Ltd. ADR (NYSE: RDY) is -3.04% lower on its value in year-to-date trading and has touched a low of $13.43 and a high of $16.89 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RDY stock was last observed hovering at around $15.42 in the last trading session, with the day’s loss setting it -0.11%.
Currently trading at $15.31, the stock is 0.10% and 3.36% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.4 million and changing -0.71% at the moment leaves the stock 0.98% off its SMA200. RDY registered 9.62% gain for a year compared to 6-month loss of -3.82%. The firm has a 50-day simple moving average (SMA 50) of $14.80688 and a 200-day simple moving average (SMA200) of $15.15738.
The stock witnessed a 6.91% gain in the last 1 month and extending the period to 3 months gives it a -0.92%, and is -0.84% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.77% over the week and 1.37% over the month.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) has around 27048 employees, a market worth around $12.75B and $3.60B in sales. Current P/E ratio is 19.96 and Fwd P/E is 18.83. Profit margin for the company is 17.79%. Distance from 52-week low is 13.98% and -9.37% from its 52-week high. The company has generated returns on investments over the last 12 months (17.14%).
with sales reaching $81.43B over the same period.The EPS is expected to grow by 1.19% this year, but quarterly earnings will post 15.24% year-over-year. Quarterly sales are estimated to grow 12.87% in year-over-year returns.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) Top Institutional Holders
The shares outstanding are 834.38M, and float is at 833.03M with Short Float at 1.57%.
The top institutional shareholder in the company is JPMORGAN CHASE & CO with over 0.64 million shares valued at $48.67 million. The investor’s holdings represent 1.9149% of the RDY Shares outstanding. As of 2024-06-30, the second largest holder is ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. with 2.07 million shares valued at $157.65 million to account for 1.2427 of the shares outstanding. The other top investors are ROYAL BANK OF CANADA which holds 2.06 million shares representing 1.2345% and valued at over $156.61 million, while MORGAN STANLEY holds 1.2191 of the shares totaling 2.03 million with a market value of $154.67 million.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) Insider Activity
#####
